YR0136
Human VEGF-A Monoclonal Antibody, Endotoxin 0.05 EU/mg
Größe
£1,617.00
- SKU:
- YR0136
- Zusätzliche Namen:
- L-VEGF|MVCD1|VEGF|VPF
- Anwendung:
- ELISA, FuncS, Neutralisation
- Molekulargewicht:
- 150 kDa
- Reinheit:
- >95%
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Abclonal
- Immunogen:
- Human VEGF-A
- Formulierung:
- Purified from cell culture supernatant in an animal-free facility
- Uniprot:
- P15692
- Synonyme:
- MVCD1;vascular endothelial growth factor A;vascular endothelial growth factor A121;vascular endothelial growth factor A165;vascular permeability factor;VEGF;VPF
- Weitere Details:
- Brolucizumab is a monoclonal antibody indicated to treat neovascular age related macular degeneration. Brolucizumab is a vascular endothelial growth factor (VEGF) inhibitor which targets the major VEGF-A isoforms: VEGF110, VEGF121, and VEGF165. Inhibition of these VEGF-A isoforms reduce proliferation of endothelial cells, vascularization of the tissue, and permeability of the vasculature.
- Versandbedingungen:
- Blue Ice